Insulin Resistance and Cardiovascular Disease Risk in Black People of the African Diaspora

Current Cardiovascular Risk Reports

Volumn 4, Issue 3, 2010, Pages 186-194

  Gaillard, Trudy ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

African Diaspora; Cardiovascular disease; Insulin resistance

Indexed keywords

EID: 79952713385     PISSN: 19329520     EISSN: 19329563     Source Type: Journal    
DOI: 10.1007/s12170-010-0092-x     Document Type: Review

References (55)

1. Gillum R, Mussolino M, Madans J: Diabetes mellitus, coronary heart disease incidence, and death from all cause in African American and European American women. The NHANES I Epidemiologic Follow-up Study. J Clin Epidemiol 2000, 53: 511-518.
2. •• Gu Q, Burt VL, Paulose-Ram R, et al.: High blood pressure and cardiovascular disease mortality risk among U. S. adults: the third National Health and Nutrition Examination Survey mortality follow-up study. Ann Epidemiol 2008, 18: 302-309. This article examines the association between hypertension and CVD risks.
3. Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001, 285: 2486-2497.
4. Albert K, Simmet P, Shaw J: Metabolic syndrome-a new world-wide definition. A consensus statement from the International Diabetes Federation. Diabetic Med 2006, 23: 469-480.
5. World Health Organization: Definition, Diagnosis, and Classification of Diabetes Mellitus and Its Complications: Report of a WHO Consultation, Part 1: Diagnosis and Classification of Diabetes Mellitus. Geneva, Switzerland: World Health Organization; 1999.
6. Ford ES, Giles WH, Mokdad AH: Increasing prevalence of the metabolic syndrome among US Adults. Diabetes Care 2004, 27: 2444-2449.
7. •• Talyor H, Liu J, Wilson G, et al.: Distinct component profiles and high risk among African Americans with the Metabolic Syndrome: the Jackson Heart Study. Diabetes Care 2008, 31: 1248-1252. This article reviews MetS and its components in a large sample of African Americans.
8. •• Gaillard T, Schuster D, Osei K: Independent role of blood pressure on cardiovascular risk factors in nondiabetic, obese African American Women: Implications for metabolic syndrome thresholds. J Am Soc Hypertens 2009, 3: 25-34. This articles discusses the importance of blood pressure in identifying African American women at high risk for MetS.
9. Njelekela M, Mpembeni R, Muhihi A, et al.: Gender differences in the prevalence of cardiovascular risk factors and their correlates in urban Tanzania. BMC Cardiovasc Disord 2009, 9: 30.
10. Garrido RA, Semeraro MB, Temesgen SM, Simi MR: Metabolic syndrome and obesity among workers at Kanye Seventh-Day Adventist Hospital, Botswana. S Afr Med J 2009, 99: 331-334.
11. •• Fezeu L, Balkau B, Kengne AP, et al.: Metabolic syndrome in a sub-Saharan African setting: central obesity may be the key determinant. Atherosclerosis 2007, 193: 70-76. This article is important in describing MetS in native Africans.
12. Kalk W, Joffe B: The metabolic syndrome, insulin resistance and its surrogates in African and White subjects with type 2 diabetes in South Africa. Metabol Syndr Related Disord 2008, 6: 247-255.
13. •• Jennings CL, Lambert EV, Collins M, et al.: Determinants of insulin-resistant phenotypes in normal weight and obese black African Women. Obesity 2008, 10: 1-8. This article is one of the first to examine the relationship between visceral adiposity and insulin resistance in black and white South African women.
14. Kelliny C, William J, Riesen W, et al.: Metabolic syndrome according to different definitions in a rapidly developing country of the African region. Cardiovasc Diabetol 2008, 7: 27.
15. Tillin T, Foeouhi N, Johnson DG, et al.: Metabolic Syndrome and coronary heart disease in South Asians, African-Caribbeans and White Europeans: a UK population-based cross-sectional study. Diabetologia 2005, 48: 649-656.
16. •• Gaillard T, Schuster D, Osei K: Metabolic syndrome in Black people of the African Diaspora: the paradox of current classification, definition and criteria. Ethn Dis 2009, 19(Suppl 2): S1-7. This article is a description of the metabolic paradox of MetS and its components in the African Diaspora.
17. •• Lea J, Greene EL, Nicholas SB, et al.: Cardiorenal metabolic syndrome in the African Diaspora: rationale for including chronic kidney disease in the metabolic syndrome definition. Ethn Dis 2009, 19(Suppl 2): 11 S-14. This article includes the importance of a measure of kidney function in defining MetS in African Americans.
18. Howard G, O'Leary DH, Zaccaro D, et al.: Insulin sensitivity and atherosclerosis. The Insulin Resistance Atherosclerosis Study (IRAS) Investigators. Circulation 1996, 93: 1809-1817.
19. Lteif A, Han K, Mather K: Obesity, insulin resistance, and the metabolic syndrome: determinants of endothelial dysfunction in whites and blacks. Circulation 2005, 112: 32-38.
20. Haffner SM, D'Agostino R Jr, Saad MF, et al.: Increased insulin resistance and insulin secretion in nondiabetic African-Americans and Hispanics compared with non-Hispanic whites. The Insulin Resistance Atherosclerosis Study. Diabetes 1996, 45: 742-747.
21. Osei K, Schuster DA: Effects of ethnicity and race on insulin sensitivity, ambulatory blood pressure and heart rates in three ethnic populations: comparative studies in African Americans, Ghanaian immigrants and white Americans. Am J Hypertens 1996, 9: 1157-1164.
22. Hutchinson RG, Watson RL, Davis CE, et al.: Racial differences in risk factors for atherosclerosis. The ARIC study: Atherosclerosis Risk in Communities. Angiology 1997, 48: 279-290.
23. Carnethon MR, Loria CM, Hill JO, et al.: Risk factors for the metabolic syndrome: The Coronary Artery Risk Development in Young Adults (CARDIA) study, 1985-2001. Diabetes Care 2004, 27: 2707-2715.
24. Srinivisan SR, Myers L, Berenson GS: Predictability of childhood adiposity and insulin for developing insulin résistance syndrome (Syndrome X) in young adulthood. The Bogalusa Heart Study. Diabetes 2002, 51: 204-209.
25. Schutte A, Rooyen J, Huisman H, et al.: Factor analysis of possible risks for hypertension in a black South African population. J Hum Hypertens 2003, 17: 339-348.
26. Amoah AB, Owusu SK, Schuster DP, et al.: Insulin sensitivity and cardiovascular risk factors in hypertensive and normotensive native Ghanaians. Diabetologia 2003, 46: 949-955.
27. Agyemang C, Bhopal R: Is the blood pressure of people from African origin adults in the UK higher or lower than that in European origin white people? A review of cross-sectional data. J Hum Hypertens 2003, 17: 523-534.
28. Chaturvedi N, McKeigue P, Marmot MG: Relationship of glucose intolerance to coronary risk in Afro-Caribbeans compared with Europeans. Diabetologia 1994, 37: 765-772.
29. Gaillard T, Schuster D, Osei K: differential impact of serum glucose, triglycerides and hdl-c on cardiovascular risk factor burden in nondiabetic, obese African American women: implications for the prevalence of metabolic syndrome. Metabolism 2010 (in press).
30. Meis SB, Schsuter D, Gaillard T, Osei K: Metabolic syndrome in non-diabetic, obese first degree relatives of African American patients with type 2 diabetes. African American Triglycerides-HDL-and insulin resistance paradox. Ethn Dis 2006, 16: 830-836.
31. Bakari A, Onyemelukwe K: Insulin resistance in type 2 diabetic Nigerians. Int J Diabetes Metab 2005, 13: 24-27.
32. Stein M, Lang C, Singh I, et al.: Increased vascular adrenergic vasoconstriction and decreased vasodilation in blacks: additive mechanisms leading to enhanced vascular reactivity. Hypertension 2000, 36: 945-951.
33. •• Li C, Ford E, Meng Y, et al.: Does the association of the triglyceride to high-density lipoprotein cholesterol ratio with fasting serum insulin differ by race/ethnicity? Cardiovasc Diabetol 2008, 7: 4. This articles examines the paradox in triglycerides and HDL-C and insulin resistance by race/ethnicity.
34. Sumner A, Vega G, Genovese D, et al.: Normal triglyceride levels despite insulin resistance in African Americans: role of lipoprotein lipase. Metabolic Synd 2004, 54: 902-909.
35. Sumner AE, Finley KB, Genovese DJ, et al.: Fasting triglycerides and the triglyceride-HDL-Cholesterol ratio are not markers of insulin resistance in African Americans. Arch Intern Med 2005, 165: 1395-1400.
36. Zoratti R: A review on ethnic difference in plasma triglycerides and high-density lipoprotein cholesterol: is the lipid pattern the key factor for the low coronary heart disease rates in people of African origins? Eur J Epidemiol 1998, 14: 9-21.
37. Haffner SM, D'Agistino RA, Goff D, et al.: LDL size in African Americans, Hispanics and non-Hispanic whites: the Insulin Resistance Atherosclerosis Study. Arteriol Thromb Vasc Biol 1999, 39: 2234-2240.
38. Kengne A, Amoah A, Mbanya J: Cardiovascular complications of diabetes mellitus in Sub-Saharan Africa. Circulation 2005, 112: 3592-3601.
39. •• Song Y, Manson JE, Tinker L, et al.: Insulin sensitivity and insulin secretion determined by homeostasis model assessment and risk of diabetes in a multiethnic cohort of women: The Women's Health Initiative Observational Study. Diabetes Care 2007, 30: 1747-1752.
40. Osei K, Schuster DP, Owusu SK, Amoah AG: Race and ethnicity determine serum insulin and c-peptide concentrations and hepatic insulin extraction and insulin clearance: comparative studies of three populations of West African Ancestry and White Americans. Metabolism 1997, 46: 53-58.
41. Osei K, Rhinesmith S, Gaillard T, Schuster D: Impaired insulin sensitivity, insulin secretion, and glucose effectiveness predict future development of impaired glucose tolerance and type 2 diabetes in pre-diabetic African Americans: implications for primary diabetes prevention. Diabetes Care 2004, 27: 1439-1446.
42. Amoah AB, Owusu SK, Schuster DP, et al.: Insulin resistance, beta cell function and cardiovascular risk in Ghanaians: varying degrees of glucose tolerance. Ethn Dis 2002, 12: S3-10.
43. •• Kelly T, Yang W, Chen C, et al.: Global burden of obesity in 2005 and projections to 2030. Int J Obesity 2008, 32: 1431-1437. This article provides data regarding the global burden of obesity and projections of its prevalence in the near future.
44. Mokdad A, Bowman B, Ford E, et al.: The continuing epidemics of obesity and diabetes in the United States. JAMA 2001, 286: 1195-1200.
45. Amoah A: Sociodemographic variations in obesity among Ghanaian adults. Public Health Nutr 2003, 6: 751-757.
46. • Sobngwi E, Effoe V, Boudou P, et al.: Waist circumference does not predict circulating adiponectin levels in sub-Saharan women. Cardiovasc Diabetol 2007, 6: 31. This article discusses the relationship of obesity and adiponectin in Native Africans.
47. Nemesure B, Wu SY, Hennis A, Leske MC; BES Study Group: The relationship of body mass index and waist-hip ratio on the 9-year incidence of diabetes and hypertension in a predominantly African-origin population. Ann Epidemiol 2008, 18: 657-663.
48. Crowther NJ, Ferris WF, Ojwang PP, Rheeder P: The effect of abdominal obesity on insulin sensitivity and serum lipid and cytokine concentrations in African women. Clin Endocrinol 2006, 64: 535-541.
49. •• Wang Y, Beydoun M, Liang L, et al.: Will all americans become overweight or obese? estimating the progression and cost of the US obesity epidemic. Obesity 2008, 16: 2323-2330. This article discusses the cost of obesity in the United States.
50. Banerji MA, Lebovitz HE: Insulin-sensitive and insulin-resistant variants in NIDDM. Diabetes 1989, 38: 784-792.
51. Sowers M, Derby C, Jannausch M, et al.: Insulin resistance, hemostatic factors, and hormone interactions in pre- and perimenopausal women: SWAN. J Clin Endocrinol Metab 2003, 88: 4904-4910.
52. Osei K, Scott R, Gaillard T, Schuster D: Plasma adiponectin in first degree relatives of African Americans parents with type 2 diabetes with normal glucose tolerance, impaired glucose tolerance and type 2 diabetes Obes Res 2005, 13: 179-185.
53. Hulver MW, Saleh O, MacDonald KG, et al.: Ethnic differences in adiponectin levels. Metabolism 2004, 53: 1-5.
54. Duncan BB, Schmidt MI, Pankow JS, et al.: Adiponectin and the development of type 2 diabetes: the atherosclerosis risk in communities study. Diabetes 2004, 53: 2473-2478.
55. Miljkovic-Garcic I, Wang X, Kammerer C, Bunker C, Wheeler V, Patrick A, Kuller L, Evans R, et al.: Genetic determination of adiponectin and its relationship with body fat topography in multigenerational families of African heritage. Metabolism 2007, 56: 234-238.